Building a lasting business can take an exceedingly long time, but it's nothing compared to hundreds of well-known, ...

Jim Geraghty is the senior political correspondent of National Review. How one foundation is helping Ukrainian veterans. Interviews with two Ukrainian evangelical Protestant pastors serving in ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

The 2025 NFL Draft season kicks off as the teams meet the top college prospects at the combine in Indianapolis. Stafford wasn’t going to fall into the same trap that has swallowed precious years ...

© 2025 The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.